NAPSRX FINAL EXAM QUESTION AND ANSWERS WITH SOLUTIONS 2024

NAPSRX FINAL EXAM QUESTION AND
ANSWERS WITH SOLUTIONS 2024
1.EHowEareEdrugsEsortedEintoEtherapeuticEgroupsEandEclasses?
A.EfirstEbyEtheEconditionsEthatEtheyEareEusedEtoEtreat.EandEthenEbyEtheirEmechanismsEofEaction
B.EfirstEbyEtheirEmechanismsEofEaction.EandEthenEbyEtheirEtherapeuticEeffects
C.EfirstEbyEtheirEsideEeffects.EandEthenEbyEtheirEtherapeuticEeffects
D.EfirstEbyEtheirEtoxicity.EandEthenEbyEtheirEeffectiveness

2.EBoneEmarrowEtransplants…
A.ErequireEthatEtheEpatientEfirstEundergoEchemotherapyEorEradiationEtoEkillEtheEdiseasedEstemEcellsEandEpro
moteEwhiteEbloodEcellEproduction.
B.EareEaEtypeEofEstemEcellEtherapy.EunlessEpatient’sEownEcellsEareEreinjected.
C.EareEalwaysEaEtypeEofEstemEcellEtherapy.
D.EcanEhelpEpeopleEwithEleukemia.EaEconditionEinEwhichEtheEbodyEdoesEnotEproduceEenoughEwhiteEbloodEc
ells.
E



3.EWhatEdoesEAMAEstandEfor?
A.EAmericanEMedicalEAcademy
B.EAmericanEMedicalEAccreditation
C.EAmericanEMedicalEAssociation
D.EAssociationEofEMedicalEAssistants
E



4.EWhatEsectionEofEaEdrug’sEpackageEinsertEdescribesEsituationsEinEwhichEtheEdrugEshouldEnotEbeEusedEbe
causeEtheErisksEoutweighEtheEtherapeuticEbenefits?
A.EadverseEreactions
B.Econtraindications
C.Eoverdosage
D.Ewarning/precautions
E



5EWhatEisEtertiaryEcare?
A.EaddingEmedicationsEtogetherEtoEachieveEaEbetterEclinicalEeffect
B.EhighlyEspecializedEmedicalEandEsurgicalEcareEprovidedEbyEaElargeEmedicalEcenterEforEunusualEorEcomplexE
medicalEproblemsENAPSRxEFinalEExamEQuestionEandEAnswers
C.EreceivingEmedicalEorEsurgicalEcareEthatEdoesEnotErequireEanEovernightEstayEinEtheEtreatmentEfacility
D.EseeingEaEphysicianEforEroutineEcheckupsEandEgeneralEhealthcare
E



6.EWhichEofEtheEfollowingEisENOTEoneEofEtheEstagesEinEtheEclassicEapproachEtoEbrandEdevelopmentEstrate
gyEcoveredEinEyourEmanual?
A.EbrandEpersonality
B.EbrandEpositoning

,C.EbrandEquality
D.EbrandEvalues
E



7EWhatEareEvasodilatorsEusedEtoEdo?
A.EdecreaseEvascularEresistanceEandEincreaseEbloodEflow
B.EmimicEpathogensEtoEstimulateEtheEimmuneEsystem
C.EnarrowEtheEbloodEvessels
D.stimulateEtheECNSEtoEmakeEtheEheartEbeatEfaster
E



8.EWhatEisEtheEnameEofEtheEconditionEthatEoccursEafterEaEspecificEdoseEofEaEdrugEisEgivenEatEsuchEregularEi
ntervalsEthatEabsorptionEandEeliminationE(andEthereforeEdrugEplasmaEconcentration)EhaveEbecomeEfairl
yEconstant?ENAPSRxEFinalEExamEQuestionEandEAnswers
A.Ehomeostasis
B.EsteadyEstate
C.Etitration
D.Etolerance
E



9.EWhichEstatementEisETRUEEaboutEocularEadministration?
A.EOcularEadministrationEisEprimarilyEforEdrugsEthatEmustEcrossEtheEblood-brainEbarrier.
B.EOcularEadministrationEisEusedEprimarilyEtoEtreatEtheEeye.
C.EOcularEadministrationEisEusedEwhenEaEdrugEmustEenterEtheEbloodstreamEimmediately.
D.EOcularEadministrationEisEusedEwhenEaEdrugEmustEproduceEimmediateEeffectsEonEtheEbrainEorEspinalEcord
.


10.EWhichEentitiesEinvest’sEtheEmostEmoneyEinEpharmaceuticalER&D?
A.ECanadianEpharmaceuticalEcompanies
B.EtheENIH
C.EtheEU.S.EGovernment
D.EU.S.EpharmaceuticalEcompanies
E


11.EHowEareEmostEdrugsEexcreted?
A.EviaEtheEbloodstream
B.EviaEtheEheart
C.EviaEtheEkidneys
D.EviaEtheEskin
E


12.EOverEtheElastEfewEdecades,EwhatEhasEhappenedEtoElegalElimitationsEonEsales’ErepsEdiscussionsEaboutE
offElabelEuses?
A.ELimitationsEhaveEdecreased.
B.ELimitationsEhaveEincreasedEsignificantly.

, C.ELimitationsEhaveEincreasedEslightly.
D.ELimitationsEhaveEremainedEaboutEtheEsame.
E



13.EAnswer:EBrandingEname
E



14.EWhatEdoesEitEmeanEifEtwoEdrugsEareEatEparity?
A.EBothEdrugsEareEessentiallyEinEaEneutralEposition.
B.EBothEdrugsEareEgenerics.
C.EBothEdrugsEhaveEexclusiveEpreferredEstatus.
D.ETheEtwoEdrugsEareEbioequivalent.
E



15EWhoEisEmostElikelyEtoEbenefitEfromEelectronicEsamplingEprograms?
A.EEveryoneEwouldEbenefitEequallyEfromEelectronicEsamplingEprograms
B.EphysiciansEinEhospitalsEwhoEareEtooEbusyEtoEseeErepresentatives
C.EphysiciansEinEruralEareasEwhoEareEnotEasEfrequentlyEvisitedEbyErepresentatives
D.EphysiciansEinEurbanEareasEwhoEareEtooEbusyEtoEseeErepresentatives
E



16.EWhenEreferringEtoEmedicationEdosage,EwhichEabbreviationEmeansE“one-half’:
A.EMS
B.EOH
C.ESM
D.ESS
E



17EWhatEisEanEinternist?
A.EaEphysicianEwhoEpracticesEinternalEmedicine
B.EaEphysician’sEintern
C.EaEtypeEofEoncologistEwhoEspecializesEinEchemotherapy
D.EanEinternalEsalesErepresentative
E



18.EWhichEofEtheEfollowingEisEaEtypeEofEwhiteEbloodEcell?
A.Eerythrocytes
B.Einsulin
C.ELymphocytes
D.HCs
E



19.EWhyEareEnoviceEsalesErepresentativesEoftenEplacedEinEchargeEofEnegotiatingEMCOEformularies?
A.EtoEbecomeEmoreEfamiliarEwithEtheEhealthcareEindustry
B.EtoEbecomeEmoreEfamiliarEwithEtheirEterritories
C.EP&TEcommitteesEareEmoreEreceptiveEtoEnewEfaces.
D.ETheyEareEnot.EThisEjobEisEusuallyEreservedEforEmoreEexperiencedEreps.